XML 35 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
Shareholders' Equity (Tables)
 9 Months Ended
Oct. 02, 2022
Equity [Abstract]  
Schedule of Earnings (Loss) Per Share The following table sets forth the computation of basic and diluted earnings/(loss) per share:
Three Months EndedNine Months Ended
October 2, 2022October 3, 2021October 2, 2022October 3, 2021
Numerator:
Net income/(loss) attributable to Sonoco$122,229 $111,140 $369,234 $(150,634)
Denominator:
Weighted average common shares outstanding:
Basic98,013 98,955 97,978 100,039 
Dilutive effect of stock-based compensation749 470 691 — 
Diluted98,762 99,425 98,669 100,039 
Net income/(loss) attributable to Sonoco per common share:
Basic$1.25 $1.12 $3.77 $(1.51)
Diluted$1.24 $1.12 $3.74 $(1.51)
Cash dividends$0.49 $0.45 $1.43 $1.35 
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share
The average numbers of SARs that were anti-dilutive and, therefore, not included in the computation of diluted earnings per share during the three- and nine-month periods ended October 2, 2022 and October 3, 2021 were as follows (in thousands):
Three Months EndedNine Months Ended
October 2, 2022October 3, 2021October 2, 2022October 3, 2021
Anti-dilutive stock appreciation rights366 — 380 142 
The following table sets forth the potentially dilutive securities excluded from the computation of diluted net loss per share during the nine-month period ended October 3, 2021:
Nine Months Ended
October 3, 2021
Dilutive securities excluded due to reported loss469